Lead Phlebotomist
GRIFOLS, S.A.
Summary
Assists in determining the suitability of donors to undergo plasmapheresis prior to venipuncture.
Job description
Responds to and assists with handling donor reactions in accordance with guidelines.
Monitors donor and equipment to ensure health of donors and quality of product.
Sets up, disconnects and operates the automated plasmapheresis machines including response and evaluation of all autopheresis troubleshooting displays, documentation of exceptions, etc.
Ensures the proper calibration and maintenance of autopheresis machines and associated equipment.
May be trained to repair plasma equipment.
Disconnects and disposes of all contaminated disposable equipment.
Ensures proper cleaning of equipment and work area between donors.
Maintains accurate and thorough documentation of production records.
Ensures donor confidentiality.
Builds rapport with donors to ensure overall customer satisfaction with the center to support long-term donation.
Learns and maintains thorough familiarity and compliance with all state and federal regulations, FDA-approved Standard Operating Procedure Manual, Occupational Safety and Health Administration (OSHA), Clinical Laboratory Improvement Amendments (CLIA), Current Good Manufacturing Practice (cGMP) and internal company procedures.
Reports all unsafe situations or conditions to area lead, supervisor or manager.
Cross trained and works in other areas to ensure efficient center operations.
Requirements
- High School diploma or GED
- Obtains required state licensures or certifications where applicable
- Typically requires 2 years of related experience
- Ability to stand 6 to 8 hours per day
- Light lifting of 15 lbs with a maximum lift of 50 lbs
- Hearing acuity essential
- Color perception/discrimination and correctable near and far vision
- Able to comprehend and follow instructions
Company overview
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines, founded in Barcelona, Spain in 1909. As the European leader and third largest plasma-derived medicine manufacturer worldwide, Grifols specializes in developing, producing, and marketing essential plasma-derived protein therapies for patients suffering from rare, chronic, and life-threatening conditions. The company operates across four main business units: Biopharma (plasma-derived medicines), Diagnostic (transfusion medicine and clinical diagnostics), Bio Supplies (biological materials for research), and Healthcare Solutions for Hospitals. With over 23,800 employees serving more than 110 countries, Grifols maintains 15 industrial facilities across seven countries and operates approximately 400 plasma donation centers globally. The company focuses on therapeutic areas including immunology, infectious diseases, pulmonology, hematology, hepatology, intensive care, and neurology, with more than 1,200 researchers working across 12 R&D centers worldwide. Grifols is publicly traded on both the Madrid Stock Exchange (GRF) and NASDAQ (GRFS), generating approximately €7.2 billion in annual revenue.